Kawada Satoshi, Morita Hiroshi, Watanabe Atsuyuki, Ito Hiroshi
Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Department of Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
J Cardiol Cases. 2018 Dec 6;19(1):36-39. doi: 10.1016/j.jccase.2018.09.004. eCollection 2019 Jan.
Patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) frequently have atrial arrhythmias, such as atrial tachycardia (AT) and fibrillation (AF), in addition to the ventricular tachyarrhythmias. The development of AT/AF in patients with CPVT is associated with adverse outcomes, and its management is still challenging. A 43-year-old woman with CPVT underwent radiofrequency catheter ablation (RFCA) for drug-refractory AT/AF. Pulmonary vein isolation (PVI) was carried out prior to AT ablation. Repetitive rapid firing from the left superior PV occurred frequently during PVI. After completion of PVI, the firing disappeared, but both polymorphic VT and multifocal ATs were induced by infusion of isoproterenol (ISP) (0.5 mcg/min). The origins of the two ATs were in the right atrium (RA) posterior septum [cycle length (CL), 285 ms] and ostium of the coronary sinus (CS) (CL, 235 ms). Electrophysiologic evaluation revealed that the earliest activation occurred at the RA posterior septum and CS ostium, preceding the onset of P waves by 52 ms and 84 ms, respectively. Application of radiofrequency energy at the site terminated ATs. After RFCA of the two ATs and PVI, no atrial tachyarrhythmias were induced by continuous ISP administration (0.5 mcg/min). < A 43-year-old woman with catecholaminergic polymorphic ventricular tachycardia (CPVT) underwent radiofrequency catheter ablation (RFCA) for drug-refractory atrial tachyarrhythmias (AT/AF). Catecholamine hypersensitivities were observed in the right atrium and pulmonary veins (PVs) as well as the ventricle. Multiple ATs originating from not only a PV but also non-PVs should be considered for elimination of AT/AF in CPVT patients.>.
儿茶酚胺能多形性室性心动过速(CPVT)患者除室性快速心律失常外,还常伴有房性心律失常,如房性心动过速(AT)和心房颤动(AF)。CPVT患者发生AT/AF与不良预后相关,其治疗仍具有挑战性。一名43岁的CPVT女性患者因药物难治性AT/AF接受了射频导管消融(RFCA)治疗。在进行AT消融之前先进行了肺静脉隔离(PVI)。在PVI期间,左上肺静脉频繁出现反复快速发放电活动。PVI完成后,这种发放电活动消失,但静脉滴注异丙肾上腺素(ISP,0.5微克/分钟)可诱发多形性室性心动过速和多灶性房性心动过速。两种房性心动过速的起源分别位于右心房(RA)后间隔[周长(CL),285毫秒]和冠状窦口(CS)(CL,235毫秒)。电生理评估显示,最早激动分别发生在RA后间隔和CS口,分别比P波起始提前52毫秒和84毫秒。在该部位施加射频能量可终止房性心动过速。对这两种房性心动过速进行RFCA及PVI后,持续静脉滴注ISP(0.5微克/分钟)未诱发房性快速心律失常。<一名43岁的儿茶酚胺能多形性室性心动过速(CPVT)女性患者因药物难治性房性快速心律失常(AT/AF)接受了射频导管消融(RFCA)治疗。在右心房、肺静脉(PVs)以及心室中均观察到儿茶酚胺超敏反应。对于CPVT患者,为消除AT/AF,应考虑不仅消除起源于PVs的多个房性心动过速,还应消除起源于非PVs的房性心动过速。>